Global Integrated Passive Device Market is rising to a valuation of US$1,646.6 mn by 2025, says TMR
Feb 23, 2018 12:13 pm UTC| Business
ALBANY, New York, Feb. 23, 2018 -- In the highly competitive vendor landscape of the global integrated passive devices market, companies are investing more on mergers and acquisitions with the aim of expanding their...
Feb 23, 2018 12:09 pm UTC| Business
NEW YORK, Feb. 23, 2018 -- The global telemedicine market is expected to grow significantly from USD 22.94 billion in 2017 to USD 63.06 billion in 2024, at a CAGR of 15.6% from 2018 to 2024. Factors such as shortage of...
Bellicum Announces Update on Clinical Hold of U.S. BPX-501 Studies
Feb 23, 2018 12:00 pm UTC| Business
HOUSTON, Feb. 23, 2018 -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced it has...
Hill International Wins Extension to Continue Support of Port of Long Beach Expansion
Feb 23, 2018 12:00 pm UTC| Business
PHILADELPHIA and IRVINE, Calif., Feb. 23, 2018 -- Hill International (NYSE:HIL), the global leader in managing construction risk, announced it will continue serving the Port of Long Beach on the 10-year, $1.49 billion...
Potbelly Corporation Reports Results for Fourth Fiscal Quarter and Full Fiscal Year 2017
Feb 23, 2018 12:00 pm UTC| Business
CHICAGO, Feb. 23, 2018 -- Potbelly Corporation (NASDAQ:PBPB) today reported financial results for the fourth quarter and full fiscal year ended December 31, 2017. Key highlights for the fourteen weeks ended December...
Summit Therapeutics to Participate in 2018 BTIG Healthcare Conference
Feb 23, 2018 12:00 pm UTC| Business
OXFORD, United Kingdom, Feb. 23, 2018 -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and infectious diseases, announces that...
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
Feb 23, 2018 12:00 pm UTC| Business
CRESTWOOD, Ky. and CAMBRIDGE, Mass., Feb. 23, 2018 -- Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of...
U.S. payrolls exceeded expectations significantly, while the unemployment rate dropps to 4.1%.